VEXAS综合征相关血管炎
纳入89例经UBA1突变确诊的VEXAS综合征患者,中位随访3.8年,21例(23.6%)有血管炎证据,以小血管炎(19.1%)和皮肤中型血管炎(2.2%)及大血管炎(2.2%)为主,结论认为VEXAS综合征可表现为累及不同血管大小的血管炎。
要点
- 89例UBA1突变确诊的VEXAS综合征患者中,21例(23.6%)有血管炎证据。
- 血管炎亚型包括小血管炎19.1%、皮肤中型血管炎2.2%、大血管炎2.2%,无患者累及一种以上血管大小。
- 18.0%的患者有颅部症状(头痛、视力改变或颌痛),部分患者可有ANCA阳性或肾脏血管炎导致误诊。
核心结论
- VEXAS综合征在约四分之一患者中表现为累及不同血管大小的血管炎,以皮肤小血管和中型血管受累尤为常见。
- 部分患者可有ANCA抗体阳性甚至肾脏血管炎,导致误诊。
- 颅部症状常见,可模仿巨细胞动脉炎(GCA),但经证实的大血管炎症罕见。
研究设计与样本
- 纳入经UBA1突变阳性验证的VEXAS综合征患者,进行病历回顾以确定患者特征和结局。
- 血管炎诊断基于显示血管炎症的组织病理学或非侵入性血管造影发现,计算汇总统计量。
- 共89例患者符合纳入标准,均为男性,中位发病年龄66.9岁(四分位距60.1,72.7),中位随访3.8年(四分位距2.2-5.5)。
主要发现
- 中位随访3.8年(四分位距2.2-5.5)期间,21例患者(23.6%)有血管炎证据。
- 血管炎亚型包括小血管炎(19.1%)、皮肤中型血管炎(2.2%)和大血管炎(2.2%),无患者累及一种以上血管大小。
- 小血管炎患者的组织病理学多数符合皮肤白细胞破碎性血管炎,但有一例肾活检显示白细胞破碎性肾小管周围毛细血管炎。
- 18.0%的患者有颅部症状(头痛、视力改变或颌痛)。
- 另有两例无颅部症状的患者经非侵入性血管造影证实颈动脉增厚,显示大血管受累,其中一例颞动脉活检阳性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To define the prevalence, distribution and characteristics of patients with VEXAS (vacuoles, E1-enzyme, X-linked, autoinflammation, somatic) syndrome who have confirmed vasculitis. METHODS: Patients with VEXAS syndrome, verified by positive UBA1 mutation, were included. Chart review was performed to identify patient characteristics and outcomes. Vasculitis diagnosis was based on either histopathology showing vascular inflammation or non-invasive angiography findings. Summary statistics were calculated. RESULTS: Eighty-nine patients met inclusion criteria. All were male with a median age of onset of 66.9 years (interquartile range 60.1, 72.7). Median (interquartile range) follow-up was 3.8 (2.2-5.5) years, during which 21 patients (23.6%) had evidence of vasculitis. Vasculitis subtypes included small vessel vasculitis (19.1%), cutaneous medium vessel vasculitis (2.2%) and large vessel vasculitis (2.2%). No patient had more than one vessel size involved. Histopathology in small vessel vasculitis patients was consistent with cutaneous leukocytoclastic vasculitis in the majority, though one patient had leukocytoclastic peritubular capillaritis on renal biopsy. Cranial symptoms (headache, vision changes or jaw pain) were noted in 18.0%. Two additional patients not experiencing cranial symptoms exhibited large vessel involvement with confirmed carotid thickening on non-invasive angiography; one of these had a positive temporal artery biopsy. CONCLUSION: VEXAS syndrome manifests as a variable vessel vasculitis in a quarter of patients, with cutaneous small and medium vessel involvement being particularly common. Some patients may have positive ANCA serologies or even renal vasculitis leading to misdiagnosis. Cranial symptoms are common and may mimic GCA, though documented large vessel inflammation is rare.
引用
- Sullivan MM, Mead-Harvey C, Sartori-Valinotti JC, et al. Vasculitis associated with VEXAS syndrome. Rheumatology (Oxford). 2025. PMID: 39392442. doi:10.1093/rheumatology/keae550
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。